期刊文献+

非霍奇金淋巴瘤患者血清乳酸脱氢酶的变化及临床意义 被引量:2

下载PDF
导出
摘要 乳酸脱氢酶(1acticdehydrogenase,LDH)是一种糖酵解酶。广泛存在于人体组织内,以心、肾和骨骼肌含量最丰富,其次是肝、脾、胰及肺组织。正常人血清可测出此酶,在一些器官病变和恶性肿瘤时血清LDH水平升高,尤其以淋巴瘤更明届。笔者对本院2003-2007年住院治疗的68例非霍奇金淋巴瘤(NHL)患者血清LDH与分期、治疗及预后的关系进行了分析,
作者 李园 郭晓珺
出处 《浙江医学》 CAS 2013年第17期1608-1608,1616,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献7

二级参考文献22

  • 1应江山.非霍奇金淋巴瘤的预后模式及其相关因素[J].国外医学(输血及血液学分册),1996,19(1):51-53. 被引量:3
  • 2沈霞 巫向前.酶类肿瘤标志物[M].上海:上海医科大学出版社,1996.199-303.
  • 3[1]Giatromanolaki A, Harris A L. Tumor hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer. Anticancer Res, 2001, 21(6B):4317-4324.
  • 4[2]Ribatti D, Angelo V, Presta M. The discovery of angiogenic factor: A historical review. General Pharmcol, 2002, 35:227-231.
  • 5[3]Wang G L, Jiang B H, Rue E A, et al. Hypoxia-inducible factor 1 is a basic-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA, 1995, 92:5510-5514.
  • 6[4]Zelzer E. Insulin induced transcription of target genes through the hypoxia-inducible factor HIF-1a/ARNT. EMBO J, 1998, 17:5085-5094.
  • 7[5]Semenza G L. Signal transduction to hypoxia-inducible factor 1. Biochemical pharmacology, 2002, 64:993-998.
  • 8[6]Papetti M, Herman I M. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol cell Physiol, 2002, 282:C947-970.
  • 9[7]Jones A, Fujiyama C, Blanche C, et al. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clinical Cancer Res, 2001, 7:6417-6423.
  • 10[8]Chaudharry R, Bromley M, Clarke N W, et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res, 1999, 19(4C):3479-3484.

共引文献14

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部